HRT Financial’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$341K Buy
+6,170
New +$294K ﹤0.01% 2777
2025
Q4
Sell
-33,474
Closed -$1.35M 3803
2025
Q3
$1.35M Buy
33,474
+21,052
+169% +$695K 0.01% 1366
2025
Q2
$317K Buy
+12,422
New +$271K ﹤0.01% 1822
2024
Q4
Sell
-33,611
Closed -$756K 3015
2024
Q3
$756K Buy
33,611
+21,148
+170% +$408K ﹤0.01% 1389
2024
Q2
$209K Sell
12,463
-78,724
-86% -$1.27M ﹤0.01% 1645
2024
Q1
$1.18M Sell
91,187
-1,035
-1% -$12.4K 0.01% 808
2023
Q4
$1.07M Buy
+92,222
New +$1.04M 0.01% 949
2023
Q2
Sell
-32,009
Closed -$490K 3043
2023
Q1
$490K Sell
32,009
-15,561
-33% -$238K 0.01% 1402
2022
Q4
$637K Buy
47,570
+20,937
+79% +$281K 0.01% 1257
2022
Q3
$353K Buy
+26,633
New +$460K ﹤0.01% 1887
2021
Q4
Sell
-22,120
Closed -$476K 3845
2021
Q3
$476K Buy
22,120
+2,335
+12% +$56.2K ﹤0.01% 2041
2021
Q2
$571K Buy
+19,785
New +$535K 0.01% 1640

Other funds holding PAHC

HRT Financial's PAHC Position: Q1 2026 in Review

HRT Financial opened a new position in Phibro Animal Health (PAHC) in Q1 2026: 6,170 shares worth $341K. The stake represents ﹤0.01% of the portfolio and ranks #2777 among its holdings. This is a return to the name: HRT Financial previously reported a position in PAHC as recently as Q3 2025.

HRT Financial first reported a position in PAHC in Q2 2021 and has held it in 12 quarters since. The position peaked at $1.35M in Q3 2025. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

  • HRT Financial held 6,170 shares of Phibro Animal Health worth $341K as of Q1 2026.
  • Phibro Animal Health was a new HRT Financial position in Q1 2026.
  • Phibro Animal Health made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #2777 holding.
  • HRT Financial first reported a position in Phibro Animal Health in Q2 2021 and has held it in 12 quarters since.
  • HRT Financial's Phibro Animal Health position peaked at $1.35M in Q3 2025.
  • 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.